Aspects regarding the use of drugs among athletes

1. Mifsud J., Attard D., Attard L. (2011). Drug doping in sports: an overview and recommendations for the Maltese context, Malta Medical Journal, 23, 01,16-21.Search in Google Scholar

2. Reardon C.L., Creado S. (2014). Drug abuse in athletes, Substance abuse and Rehabilitation, 5, 95-105.10.2147/SAR.S53784Search in Google Scholar

3. Baron D.A., Martin D.M., Abol Magd S. (2007). Doping in sports and its spread to at-risk population: an international review, World Psychiatry, 6, 118-123.Search in Google Scholar

4. Momaya A., Fawal M., Estes R. (2015). Performance-enhancing substances in sports: a review of the literature, Sports Med., 45, 517-531.Search in Google Scholar

5. Botre F., Pavan A. (2009). Enhancement drugs and the athlete, Phys. Med. Rehabil. Clin. N. Am., 20, 133-148.10.1016/j.pmr.2008.10.010Search in Google Scholar

6. Pițigoi G., Păunescu C., Petrescu S., Ciolan G.A., Păunescu M. (2013). Drug abuse in sport performance – a systematic review, Farmacia, 61, 6, 1037-1042.Search in Google Scholar

7. Pițigoi G., Păunescu C., Mitrea N., Baconi D., et al. (2012). New approaches regarding the dynamics of the doping pharmacologic agents in sports, Farmacia, 60, 1, 111-119.Search in Google Scholar

8. World Anti-Doping Agency. About WADA, http://www.wada-ama.org. accesed on 14 March 2016Search in Google Scholar

9. Da Silva E.R., De Rose E.H., Ribeiro J.P., et al. (2011). Non-steroidal anti-inflammatory use in the XV Pan-American Games (2007), Br. J. Sports Med., 45, 91-94.Search in Google Scholar

10. Alaranta A., Alaranta H., Heliövaara M., et al. (2006). Ample use of physician-prescribed medications in Finnish elite athletes, Int. J. Sports Med., 27, 919-925.Search in Google Scholar

11. Mottram D., Chester N., Atkinson G., et al. (2008). Athletes'knowledge and views on OTC medication, Int. J. Sports Med., 29, 851-855.Search in Google Scholar

12. Connolly D.A., Sayers S.P., McHugh M.P. (2003). Treatment and prevention of delayed onset muscle soreness, J. Strength Cond. Res., 17, 197-208.Search in Google Scholar

13. VanHeest J., Stoppani J., Scheett T.P., et al. (2002). Effects of Ibuprofen and Vicoprofen® on physical performance after exercise-induced muscle damage, J. Sport Rehabil., 11, 224-234.10.1123/jsr.11.3.224Search in Google Scholar

14. Foster J., Taylor L., Bryna C.R.C., Watkins S.L., Mauger A.R. (2014). The influence of acetaminophen on repeated sprint cycling performance, Eur. J. Appl. Psysiol., 114, 41-48.Search in Google Scholar

15. O’Connor P.J. (1992). Psychological aspects of endurance performance. In: Astrand P.O. (ed) Endurance in Sport, Blackwell Science, Oxford.Search in Google Scholar

16. Sawrymowicz M. (1997). The effect of exercise on the pharmacokinetics of acetaminophen and acetylsalicylic acid, Ann. Acad.Med. Stetin, 43, 57-66.Search in Google Scholar

17. O’Connor P.J., Cook D.B. (1999). Exercise and pain: the neurobiology, measurement, and laboratory study of pain in relation to exercise in humans, Exerc. Sport Sci. Rev., 27, 119-166.Search in Google Scholar

18. Makin A.J., Williams R. (1997). Acetaminophen-induced hepatotoxicity: predisposing factors and treatments, Adv. Intern. Med., 42, 453-483.Search in Google Scholar

19. Dobrescu D. și colab. (2007). Memomed, Cap.: Medicamentele și sportul, Ed. a XIII-a, Ed. Minesan, București, 948-952.Search in Google Scholar

20. Kindermann W. (2007). Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes?, Sports Med., 37, 95-102.Search in Google Scholar

21. Davis E., Loiacono R., Summers R.J. (2008). The rush to adrenaline: drugs in sport acting on the beta-adrenergic system, Br. J. Pharmacol., 154, 584-597.10.1038/bjp.2008.164Search in Google Scholar

22. Tarnopolsky M.A. (2010). Caffeine and creatine use in sport, Ann. Nutr. Metab., 57, suppl.2, 1-8.Search in Google Scholar

23. Glade M.J. (2010). Caffeine – not just a stimulant, Nutrition, 26, 932-938.10.1016/j.nut.2010.08.004Search in Google Scholar

24. Astorino T.A., Roberson D.W. (2010). Efficacy of acute caffeine ingestion for short-term high-intensity exercise performance: a systematic review, Journal of Strength and Conditioning Research, 24, 1, 257-26510.1519/JSC.0b013e3181c1f88aSearch in Google Scholar

25. Higgins P., Tuttle T.D., Higgins C.L. (2010). Energy beverages: content and safety, Mayo Clin. Proc., 85, 1033-1041.Search in Google Scholar

26. Branch I.D. (2003). Effect of creatine supplementation on body composition and performance: a meta-analysis, Int. J. Sport Nutr. Exerc. Metab., 13, 198-226.10.1123/ijsnem.13.2.198Search in Google Scholar

27. Balsom P.D., Soderlund K., Sjodin B., et al. (1995). Skeletal muscle metabolism during short duration high-intensity exercise: influence of creatine supplementation, Acta Physiol. Scand., 154, 303-310.10.1111/j.1748-1716.1995.tb09914.xSearch in Google Scholar

28. Earnest C.P., Snell P.G., Rodriguez R., et al. (1995). The effect of creatine monohydrate ingestion on anaerobic power indices, muscular strength and body composition, Acta Physiol. Scand., 153, 207-209.Search in Google Scholar

29. Vandebuerie F., et al. (1998). Effect of creatine loading on endurance capacity and sprint power in cyclists, Int. J. Sports Med., 19, 490-495.Search in Google Scholar

30. Aaserud R., Gramyik P., Olsen SR, et al. (1998). Creatine supplementation delays onset of fatigue during repeated bouts of sprint running, Scand. J. Med. Sci. Sports, 8, 247-251.10.1111/j.1600-0838.1998.tb00478.xSearch in Google Scholar

31. Liddle D.G., Connor D.J. (2013). Nutritional supplements and ergogenic AIDS, Prim Care, 40, 487-505.10.1016/j.pop.2013.02.009Search in Google Scholar

32. Judkins C., Prock P. (2012). Supplements and inadvertent doping – how big is the risk to athletes, Med. Sports Sci., 59, 143-152.10.1159/000341970Search in Google Scholar

33. Parnabas V.A., Mahamood Y., Parnabas J.A., et al. (2013). The drug use motivation among Malaysian athletes, Humanitas (Jurnal Psikologi Indonesia), 10(2): 1-12.10.26555/humanitas.v10i2.332Search in Google Scholar

34. Eichner E.R. (2008). Stimulants in sport, Curr. Sports Med. Rep., 7, 244-245.10.1249/JSR.0b013e318186bf44Search in Google Scholar

35. Chandler J.V., Blair S.N. (1980). The effect of amphetamines on selected physiological components related to athletic success, Med. Sci. Sports Exerc., 12, 65-69.Search in Google Scholar

36. Shekelle P.G., Hardy M.L., Morton S.C., et al. (2003). Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta analysis, JAMA, 289, 1537-1545.10.1001/jama.289.12.1537Search in Google Scholar

37. Giorgi A., Weatherby R.P., Murphy P.W. (1999). Muscular strength, body composition and health responses to the use of testosterone enanthate: a double blind study, J. Sci. Med. Sport, 2, 341-355.10.1016/S1440-2440(99)80007-3Search in Google Scholar

38. Bhasin S., Storer T.W., Berman N., et al. (1996). The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men, N. Engl. J. Med., 335, 1-7.10.1056/NEJM199607043350101Search in Google Scholar

39. Bhasin S., Woodhouse L., Casaburi R., et al. (2001). Testosterone dose-response relationship in healthy young men, Am. J. Physiol. Endocrinol. Metab., 281, E1172-E1181.Search in Google Scholar

40. Basaria S. (2010). Androgen abuse in athletes: detection and consequences, J. Clin. Endocrinol. Metab., 95, 1533-1543.10.1210/jc.2009-1579Search in Google Scholar

41. Meinhardt U., Nelson A.E., Hansen J.L., et al. (2010). The effects of growth hormone on body composition and physical performance in recreational athletes: a randomized trial, Ann. Intern Med., 152, 568-577.10.7326/0003-4819-152-9-201005040-00007Search in Google Scholar

42. Liu H., Bravata D.M., Olkin I., et al. (2008). Systematic review: the effects of growth hormone on athletic performance, Ann. Intern Med., 148, 747-758.10.7326/0003-4819-148-10-200805200-00215Search in Google Scholar

43. Holt R.I., Sonksen P.H. (2008). IGF-I and insulin and their abuse in sport, Br. J. Pharmacol., 154, 542-556.Search in Google Scholar

44. World Anti-Doping Agency (2013). The World Anti-Doping Code: The 2013 Prohibited List International Standard, https://www.wadaama.org/sites/default/files/resources/files/WADAProhibited-List-2013-EN.pdf, accesed on 14 March 2016.Search in Google Scholar

45. Elliott S. (2008). Erythropoiesis-stimulating agents and other methods to enhance oxygen transport, Br. J. Pharmacol., 154, 529-541.Search in Google Scholar

46. Davis E., Loiacono R., Summers R.J. (2008). The rush to adrenaline: drugs in sport acting on the beta-adrenergic system, Br. J. Pharmacol., 154, 584-597.10.1038/bjp.2008.164Search in Google Scholar

47. Schmitt L., Millet G., Robach P., et al. (2006). Influence of “living high-training low” on aerobic performance and economy of work in elite athletes, Eur. J. Appl. Physiol., 97, 627-636.10.1007/s00421-006-0228-3Search in Google Scholar